Pay in 4 interest-free payments of $6.18 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
These differences often stem from factors like branding, formulation, and even regional availability
When using LSM by VCTE as the second test after FIB-4, 25% of patients had LSM 12 kPa and were classified as at-risk NASH, and 36% fell into the grey zone
The Phase 2 MASH trial enrolled 293 participants with biopsy-confirmed MASH and liver fibrosis stages F1 through F3
60 Yoshino S, Tagawa T, Awa R, Ogasawara J, Kuwahara H, Fukuhara I
US$ 27.03
US$ 29.90
US$ 28.14
US$ 24.74
US$ 21.91
US$ 22.53
